FIA
ETTX

FNY Investment Advisers’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

FNY Investment Advisers’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-13,901
Closed -$56K – 1029
2018
Q4 		$56K Buy
13,901
+13,801
+13,801% +$90.9K 0.02% 224
2018
Q3 		$1K Buy
+100
New +$1.05K ﹤0.01% 832

Other funds holding ETTX

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FNY Investment Advisers's ETTX Position: Q1 2019 in Review

FNY Investment Advisers sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q1 2019, closing a stake of 13,901 shares — an estimated $56K sold.

FNY Investment Advisers first reported a position in ETTX in Q3 2018 and held it in 2 quarters. The position peaked at $56K in Q4 2018. 17 funds tracked by Wall St. Rank hold ETTX as of Q1 2019.

  • FNY Investment Advisers reported no remaining Entasis Therapeutics Holdings Inc. position as of Q1 2019 after selling out during the quarter.
  • FNY Investment Advisers sold 13,901 Entasis Therapeutics Holdings Inc. shares in Q1 2019, an estimated $56K.
  • FNY Investment Advisers first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2018 and held it in 2 quarters.
  • FNY Investment Advisers's Entasis Therapeutics Holdings Inc. position peaked at $56K in Q4 2018.
  • 17 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q1 2019.

Based on FNY Investment Advisers's 13F filing for Q1 2019, filed 17 Apr 2019.